Med Page Today
NOVEMBER 3, 2024
(MedPage Today) -- Investigational transcranial magnetic stimulation that targeted a brain network involved in memory slowed progression in mild-to-moderate Alzheimer's disease, data from a small phase II study suggested. At 1 year, noninvasive.
Dr. Smith's ECG Blog
NOVEMBER 3, 2024
Written by Magnus Nossen ( with comments and laddergram by Ken Grauer ) The patient in today’s case is a man in his 60s — who presented with palpitations and lightheadedness. He had no history of syncope. The patient had hypertension, but was otherwise healthy. Due to the reported symptoms, he was admitted for observation and put on telemetry monitoring.
CardiacWire
NOVEMBER 3, 2024
This year’s TCT conference saw a deluge of TAVR studies examining everything from the efficacy of valve designs to TAVR’s impact on aortic and tricuspid regurgitation. Out of all these TAVR studies, the four that could have the greatest clinical impact focused on interventional timing and the risk of comorbidities and procedural complications. The EARLY TAVR trial shined the brightest spotlight on TAVR timing, finding that earlier intervention in patients with asymptomatic severe AS may be more
Heart Sisters
NOVEMBER 3, 2024
What’s the deal with eggs if you have heart concerns? Registered Dietitian Cheryl Strachan wades through conflicting studies for us.
Cardiovascular Diabetology
NOVEMBER 3, 2024
Plasma ceramide plays a potentially significant role in the pathogenesis of coronary microvascular dysfunction. However, the relationship between plasma ceramide and coronary microvascular resistance in patien.
Journal of Cardiothoracic Surgery
NOVEMBER 3, 2024
Cardiac hemangioma is a rare, benign vascular primary tumor. Clinical presentation is either asymptomatic or with symptoms due to its location and spatial interaction with adjacent structures. The authors pres.
HCPLive
NOVEMBER 3, 2024
The rheumatology month in review emphasizes new data on secukinumab, gout clinical decision making, and addressing sleep issues in fibromyalgia.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Circulation
NOVEMBER 3, 2024
Circulation, Volume 150, Issue 19 , Page 1481-1483, November 5, 2024.
Journal of Cardiovascular Electrophysiology
NOVEMBER 3, 2024
Abstract Objective The potential risk of inducing ventricular arrhythmias was explored by employing pulsed field ablation (PFA) through the administration of both monophasic and biphasic waveform deliveries. Methods PFA was applied to specific locations in the right ventricle (RV, n = 5 sites) in swine ( n = 2), utilizing identical settings with consistent amplitude, pulse width, and a number of pulses for both monophasic and biphasic waveforms.
Circulation
NOVEMBER 3, 2024
Circulation, Volume 150, Issue 19 , Page 1484-1486, November 5, 2024.
Circulation
NOVEMBER 3, 2024
Circulation, Volume 150, Issue 19 , Page 1505-1507, November 5, 2024.
Circulation
NOVEMBER 3, 2024
Circulation, Volume 150, Issue 19 , Page 1487-1489, November 5, 2024.
Expert insights. Personalized for you.
126 
Let's personalize your content